Shanghai MicroPort MedBot Group Co. Ltd. has announced the successful completion of the placement of new H shares under a general mandate. This strategic move aims to bolster the company's capital and support its growth initiatives. The process involved the issuance of 55,300,000 shares, comprising 30,163,500 sale shares and 25,136,500 placing shares. The company remains committed to expanding its operations and enhancing shareholder value. The executive team, led by Chairman Mr. Sun Hongbin, includes key figures such as Dr. He Chao and Ms. Fang Cong, who continue to drive the company's strategic objectives.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.